Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
Ducommun
DCO
$3.04B
| $210K | ﹤0.01% |
6,016
+2,291
| +62% | +$67.8K |
|
3977
Precision BioSciences
DTIL
$205M
| $210K | ﹤0.01% |
839
+437
| +109% | +$95.7K |
|
3978
PUT
Macerich
MAC
$6.66B
| $210K | ﹤0.01% |
23,400
-55,900
| -70% | -$433K |
|
3979
Omega Flex
OFLX
$312M
| $210K | ﹤0.01% |
1,987
+630
| +46% | +$59.9K |
|
3980
Orrstown Financial Services
ORRF
$845M
| $210K | ﹤0.01% |
14,260
+10,901
| +325% | +$146K |
|
3981
PUT
Qorvo
QRVO
$8.41B
| $210K | ﹤0.01% |
1,900
-146,500
| -99% | -$14.5M |
|
3982
Cartesian Therapeutics
RNAC
$265M
| $210K | ﹤0.01% |
2,478
+1,241
| +100% | +$112K |
|
|
SABA
3983
Saba Capital Income & Opportunities Fund II
SABA
$224M
| $210K | ﹤0.01% |
16,834
| – | – |
|
|
BSTC
3984
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $210K | ﹤0.01% |
3,421
+1,386
| +68% | +$80.2K |
|
3985
Mitek Systems
MITK
$759M
| $209K | ﹤0.01% |
21,665
+8,956
| +70% | +$80.8K |
|
3986
PUT
NNN REIT
NNN
$9.02B
| $209K | ﹤0.01% |
5,900
-600
| -9% | -$19.6K |
|
3987
CALL
Banc of California
BANC
$3.01B
| $208K | ﹤0.01% |
19,200
-19,600
| -51% | -$197K |
|
3988
CALL
Popular Inc
BPOP
$11.2B
| $208K | ﹤0.01% |
5,600
-8,200
| -59% | -$305K |
|
3989
PUT
Boyd Gaming
BYD
$6.11B
| $207K | ﹤0.01% |
9,900
-25,700
| -72% | -$469K |
|
3990
Dynagas LNG Partners
DLNG
$142M
| $207K | ﹤0.01% |
+64,800
| New | +$128K |
|
|
FLIC
3991
DELISTED
First of Long Island Corp
FLIC
| $207K | ﹤0.01% |
12,708
+5,070
| +66% | +$77.7K |
|
3992
PUT
Dillards
DDS
$9.64B
| $206K | ﹤0.01% |
8,000
-5,300
| -40% | -$150K |
|
3993
CALL
Elanco Animal Health
ELAN
$12.1B
| $206K | ﹤0.01% |
9,600
-223,000
| -96% | -$4.93M |
|
3994
PUT
Equity Residential
EQR
$25B
| $206K | ﹤0.01% |
3,500
-6,600
| -65% | -$409K |
|
|
MITT
3995
PUT
TPG Mortgage Investment Trust
MITT
$222M
| $206K | ﹤0.01% |
+21,500
| New | +$205K |
|
3996
Southern First Bancshares
SFST
$604M
| $206K | ﹤0.01% |
7,432
+5,082
| +216% | +$138K |
|
3997
The Joint Corp
JYNT
$117M
| $205K | ﹤0.01% |
13,389
+7,059
| +112% | +$92.5K |
|
3998
Merchants Bancorp
MBIN
$2.48B
| $205K | ﹤0.01% |
16,659
+2,958
| +22% | +$31.2K |
|
3999
CALL
ProShares UltraPro Short QQQ
SQQQ
$1.77B
| $205K | ﹤0.01% |
43
-243
| -85% | -$1.71M |
|
|
LFC
4000
CALL
DELISTED
China Life Insurance Company Ltd.
LFC
| $205K | ﹤0.01% |
20,300
-50,100
| -71% | -$504K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.